Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a real-world chart review study
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
;
42(3): 317-321, May-June 2020. tab, graf
Artículo
en Inglés
| LILACS
| ID: biblio-1132080
ABSTRACT
Objective: Selective serotonin reuptake inhibitors (SSRIs) are the cornerstone of treatment of major depressive disorder (MDD). However, non-response is common, often necessitating combination strategies. The present study assessed the efficacy of vortioxetine as an add-on therapy in patients with SSRI-resistant MDD. Methods: The charts of 36 adult outpatients with DSM-IV-TR MDD who had not achieved a response after at least 8 weeks of treatment with an SSRI were reviewed retrospectively. Subjects were treated with vortioxetine (5-20 mg/day) for 8 weeks added to the current SSRI. The main outcome measures were change from baseline in total Hamilton Scale for Depression (HAM-D) score and the rate of response (a 50% or greater reduction in HAM-D score and a Clinical Global Impression ‐ Improvement module [CGI-I] score of 1 or 2 at endpoint). HAM-D scores ≤ 7 were considered as remission. Additional outcome measures included the Snaith-Hamilton Pleasure Scale (SHAPS) and the Scale for Suicide Ideation (SSI). Results: 32 patients completed the 8 weeks of treatment. At 8 weeks, a significant reduction in HAM-D score was observed (p ≤ 0.001), with response obtained by 41.7% and remission by 33.3% of patients. Significant reductions in SHAPS and SSI were also observed (p ≤ 0.001 for both scales). Conclusions: Adjunctive vortioxetine may be useful and well-tolerated in stage I treatment-resistant depression. However, the limitations of this study (such as small sample size, absence of randomization and control group, retrospective design, etc.) must be considered.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Trastorno Depresivo Mayor
/
Trastorno Depresivo Resistente al Tratamiento
/
Inhibidores de Captación de Serotonina y Norepinefrina
/
Vortioxetina
/
Antidepresivos
Tipo de estudio:
Estudio observacional
/
Factores de riesgo
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
Asunto de la revista:
Psiquiatria
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Italia
Institución/País de afiliación:
Federico II University/IT
/
Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, FoRiPsi/IT
/
Hospital G. Mazzini, National Health Service (NHS)/IT
/
Hospital Madonna Del Soccorso NHS/IT
/
Hospital SS. Annunziata NHS/IT
/
Hospital San Camillo de Lellis NHS/IT
/
Polyedra/IT
/
S. Andrea Hospital, Sapienza University/IT
/
University G. DAnnunzio Chieti/IT
/
University of Foggia/IT
Similares
MEDLINE
...
LILACS
LIS